Pancreas Cyst
17
8
9
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Pancreatic Cancer Early Detection Consortium
Tumour Regulatory Molecules in Early Pancreatic Cancer Detection
Blood Markers of Early Pancreas Cancer
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
Quebec Pancreas Cancer Study
Radiology Registry on Pancreatic Malignancies
A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes
Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions
Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
DNA-mutation Analysis in Cyst Fluid of Suspected Intraductal Papillary Mucinous Neoplasia of the Pancreas
Moray Micro Forceps and Pancreatic Cyst
Establishment of Abbreviated Pancreatobiliary MRI Protocol
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
Prognostic Factors in Periampullary Tumors and Cysts
ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers